Sign In

Scott Holmes

Chief Financial Officer at Catamaran Bio

Professional Background

Scott Holmes is a renowned financial expert and strategic leader in the biotechnology and pharmaceutical sectors. With a robust career that spans over two decades, Scott has successfully held several high-profile positions that have shaped the finance landscapes of multiple companies. Currently, he serves as the Chief Financial Officer at Catamaran Bio, where he leverages his extensive experience in financial planning, investor relations, and corporate governance to drive the company towards its strategic goals.

Prior to his tenure at Catamaran Bio, Scott showcased his leadership in finance by serving as the Chief Financial Officer at Disarm Therapeutics, Kiadis Pharma, and Keryx Biopharmaceuticals. At Keryx Biopharmaceuticals, he played a pivotal role in overseeing financial strategies and operational planning, facilitating significant growth and stability during his time with the organization.

Before advancing to the CFO positions, Scott held key roles at AMAG Pharmaceuticals as the Senior Vice President of Finance & Investor Relations and Treasurer, where he managed financial strategies that bolstered the company’s market position and attracted significant investor interest. His early career included a significant stint at Ernst & Young LLP as a Senior Associate in M&A, where he honed his expertise in mergers and acquisitions, giving him a solid foundation in corporate finance.

Education and Achievements

Scott’s educational background is as impressive as his career trajectory. He holds a dual Master’s degree (MS/MBA) from the Northeastern University Graduate School of Business Administration, equipping him with advanced skills in both science and business management. Additionally, he earned his Bachelor’s degree in History from Middlebury College, which underscores his analytical and critical thinking abilities—traits that are essential in the finance domain.

Throughout his career, Scott has demonstrated a consistent ability to lead finance teams towards clarity and success, establishing himself as a key player in the commercialization efforts of various biopharmaceutical products. His achievements include developing comprehensive financial strategies that align with corporate objectives and ensuring compliance with various regulations, thereby enhancing corporate governance.

Achievements

  • Successfully led financial operations as CFO at multiple pharmaceutical companies, driving growth and operational efficiency.
  • Contributed to the successful public offerings and private placements that provided these organizations with significant capital for research and development.
  • Developed and refined financial models that have proven essential in strategic planning and investor presentations, enhancing stakeholder confidence.
  • Received recognition for leadership in finance and investor relations, particularly during pivotal fundraising rounds.

tags':['CFO','finance professional','biotechnology','pharmaceuticals','financial strategy','investor relations','corporate governance','Northeastern University','Mergers and Acquisitions','Middlebury College'],

questions':[

How has Scott Holmes influenced the financial strategies at Catamaran Bio?

What are the key financial insights Scott Holmes gained from his experience in leadership roles at various pharmaceutical companies?

In what ways did Scott Holmes' educational background contribute to his success in the finance sector?

How did Scott Holmes manage investor relations through the various stages of company growth in his previous CFO roles?

What strategies did Scott Holmes implement during his tenure as Vice President of Finance at AMAG Pharmaceuticals?

Scott Holmes
Add to my network

Location

Cambridge, Massachusetts, United States